Deposition of inhaled nanoparticles, airflow obstruction and emphysema Source: International Congress 2016 – Pulmonary drug delivery Year: 2016
The effects of bronchodilators on regional lung sound distribution in patients with COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
COPD severity related to extended measurements of lung volume, diffusion, and resistance Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014
Calculation of peripheral airspace dimensions from deposition of inhaled nanoparticles Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016
Lung volume reduction coils (LVR-coils) for pulmonary emphysema: Results of the Italian National registry Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013
Unilateral treatment with lung volume reduction coils in patients with severe emphysema Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013
Bronchodilator treatment response mapping in COPD using hyperpolarised gas ventilation MRI Source: Annual Congress 2013 –The different modalities for current imaging and for future issues Year: 2013
Relationship between annual change of bone mineral density, emphysema and pulmonary function in patients with COPD Source: International Congress 2015 – COPD: notable points Year: 2015
Airway wall thinness and COPD: Analysis of spatially comparable airways. The MESA COPD study Source: Annual Congress 2013 –Functional imaging of the lung, airways and diaphragm Year: 2013
Novel jet nebulizer/holding chamber for drug delivery to the deep lung Source: International Congress 2016 – Pulmonary drug delivery Year: 2016
Lung volume reduction coil treatment restores lung compliance in patients with homogeneous emphysema Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013
Low cost biological lung volume reduction therapy for advanced emphysema Source: International Congress 2014 – Bronchoscopic treatment of emphysema: valves, coils and other Year: 2014
Pharmacological treatment of COPD in the on-sint cohort Source: International Congress 2014 – COPD exacerbations Year: 2014
Heterogeneity inside group D COPD patients: About 827 cases Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Double-tracer gas washout in stable asthma and COPD Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014
Development of a human COPD model-on-a-chip to mimic disease exacerbation (a small airway-on-a-chip model) Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014
Lung clearance index is increased in patients with COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015
Effect of aclidinium bromide on static lung function and hyperinflation in patients with moderate to severe COPD Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013
Effectiveness of a comprehensive management program of fragile COPD patients Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014
Changes in inhalation therapy after combined assessment of COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015